Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
clinical trial
Pharma
Novartis presses pause on Fabhalta lupus nephritis trial
Amid a steady advance of kidney-focused label expansions, Novartis’ Fabhalta is slowing its roll in a key potential autoimmune niche.
Fraiser Kansteiner
Oct 19, 2026 10:13am
ESC: AZ digs deep on Wainua's surprise ph. 3 failure in ATTR-CM
Aug 29, 2026 1:35pm
Pasatru approved by FDA as 2nd drug for rare bone lesion disease
Aug 19, 2026 2:35pm
Karyopharm reports Xpovio miss, FDA filing in separate cancers
Jul 31, 2026 10:00am
Veradermics reports ph. 2 win in female pattern hair loss
Jul 15, 2026 11:27am
Trial results set up BioMarin for expansion of Voxzogo
May 21, 2026 10:23am
